|

ES014 Clinical Trials

2 actively recruiting trials

No change since May 2026

Also known as: ES014 for Injection

Pipeline

Phase 2: 2

Top Sponsors

  • Elpiscience (Suzhou) Biopharma, Ltd.1
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Indications

  • Cancer2
  • Desmoid Tumor1
  • Advanced Solid Tumor1

Other2 trials

A Study in Adults With Desmoid Tumors
Phase 2
A Study of ES014 in Subjects With Advanced Solid Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.